NERV vs WY · P/E 2.2, $12.4M cap vs P/E 43, rev $3.59B
Minerva Neurosciences Inc (NERV) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
NERV does not have a complete income-statement cache yet.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
NERV currently screens at market cap $12.4M and trailing P/E 2.2. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the NERV and WY stock pages for the full models.
Not investment advice.